2764 results about "Propanol" patented technology

This invention provides a method for producing ethanol and 2-propanol from syngas, the method comprising: (a) converting syngas into methanol using a methanol-synthesis catalyst; (b) converting methanol into ethylene and propylene using a methanol-to-olefins catalyst; and (c) hydrating ethylene into ethanol and propylene into 2-propanol. As taught herein, the combined yield of the ethanol and the 2-propanol from biomass can be at least 100 gallons per dry ton biomass. In certain embodiments, the yield of ethanol is at least 100 gallons per dry ton biomass. In some embodiments, the yield of 2-propanol is at least 50 gallons per dry ton biomass.

The present invention is drawn to adhesive solidifying formulations, and methods for dermal delivery of a drug. The formulation can include a drug, a solvent vehicle, and a polyvinyl alcohol. The solvent vehicle can include a volatile solvent system including water and an alcohol solvent, e.g., ethanol, propanol, and / or isopropanol, and a non-volatile solvent system including at least one non-volatile solvent which is compatible with polyvinyl alcohol. The formulation is formulated such that the water to polyvinyl alcohol weight ratio is in the range of from about 4:1 to about 1:1, and water to alcohol solvent weight ratio in the range of from about 0.33:1 to about 6:1.

Implanted catheters are locked with a solution comprising a lower alcohol, typically ethanol, propanol, or butanol, most preferably isopropanol, and an additive, the additive comprising an anti-microbial, typically taurolidine or triclosan, or an anti-coagulant, typically riboflavin, sodium citrate, ethylene diamine tetraacetic acid, or citric acid. The use of an alcohol and additive solution can effectively reduce fouling of the catheter, particularly clotting and thrombus in intravascular catheters, as well as reduce the risk of infection. The risk of infection can be further reduced by employing a catheter body which is sufficiently porous to permit the anti-microbial solution of a lower alcohol and another anti-microbial or anti-coagulant compound to penetrate into the catheter body and preferably through the catheter into tissue surrounding the implanted catheter.

An element of an absorbent article is provided. The element has a bio-based content of at least about 50% based on the total weight of the element, and comprises a synthetic polymer derived from a renewable resource via a first intermediate compound selected from the group consisting of crotonic acid, propiolactone, ethylene oxide, i-propanol, butanol, butyric acid, propionic acid, 2-acetoxypropanoic acid, methyl 2-acetoxypropanoate, methyl lactate, ethyl lactate, polyhydroxybutyrate, and a polyhydroxyalkanoate comprising 3-hydroxypropionate monomers. An absorbent article comprising the element and a method of making an element for an absorbent article also are provided.

The use of collagen as a biomedical implant raises safety issues towards viruses and prions. The physicochemical changes and the in vitro and in vivo biocompatibility of collagen treated with heat, and by formic acid (FA), trifluoroacetic acid (TFA), tetrafluoroethanol (TFE) and hexafluoroiso-propanol (HFIP) were investigated. FA and TFA resulted in extensive depurination of nucleic acids while HFIP and TFE did so to a lesser degree. The molecules of FA, and most importantly of TFA, remained within collagen. Although these two acids induced modification in the secondary structure of collagen, resistance to collagenase was not affected and, in vitro, cell growth was not impaired. Severe dehydrothermal treatment, for example 110° C. for 1-3 days under high vacuum, also succeeded in removing completely nucleic acids. Since this treatment also leads to slight cross-linking, it could be advantageously used to eliminate prion and to stabilize gelatin products. Finally, prolonged treatment with TFA provides a transparent collagen, which transparency is further enhanced by adding glycosaminoglycans or proteoglycans, particularly hyaluronic acid. All the above treatments could offer a safe and biocompatible collagen-derived material for diverse biomedical uses, by providing a virus or prion-free product.

Implanted catheters are locked with a solution comprising a lower alcohol, typically ethanol, propanol, or butanol, in a range from 1% to 99% by volume, and an additive in a range from 1% to 99% by volume, the additive comprising an anti-microbial, typically taurolidine or triclosan, or an anti-coagulant, typically riboflavin, sodium citrate, ethylene diamine tetraacetic acid, or citric acid. The use of an alcohol and additive solution can effectively reduce fouling of the catheter, particularly clotting and thrombus in intravascular catheters, as well as eradicate existing infections and / or reduce the risk of potential infections. Existing infections and / or potential infections can be further reduced by employing a catheter body which permits an anti-microbial solution to penetrate into the catheter body and preferably through the catheter into tissue surrounding the implanted catheter.

A method for extracting prion protein from a biological material, e.g., an animal tissue or product. In a specific example, abnormal prion protein is extracted from homogenized sheep brain with hexafluoro-2-propanol. The hexafluoro-2-propanol is separated from the aqueous brain preparation by increasing the ionic strength of the aqueous solution. Prion protein in the organic extract can be further purified, or the extract can be tested, e.g., by immunoassay, for the presence of prion protein, and more particularly abnormal prion protein. The extraction process permits testing for the presence of abnormal prior protein, e.g., for diagnosis of transmissible spongiform encephalopathies (TSE).

A method for providing an anhydrous route for the synthesis of amine capped coinage-metal (copper, silver, and gold) nanoparticles (NPs) using the coinage-metal mesityl (mesityl=C6H2(CH3)3-2,4,6) derivatives. In this method, a solution of (Cu(C6H2(CH3)3)5, (Ag(C6H2(CH3)3)4, or (Au(C6H2(CH3)3)5 is dissolved in a coordinating solvent, such as a primary, secondary, or tertiary amine; primary, secondary, or tertiary phosphine, or alkyl thiol, to produce a mesityl precursor solution. This solution is subsequently injected into an organic solvent that is heated to a temperature greater than approximately 100° C. After washing with an organic solvent, such as an alcohol (including methanol, ethanol, propanol, and higher molecular-weight alcohols), oxide free coinage NP are prepared that could be extracted with a solvent, such as an aromatic solvent (including, for example, toluene, benzene, and pyridine) or an alkane (including, for example, pentane, hexane, and heptane). Characterization by UV-Vis spectroscopy and transmission electron microscopy showed that the NPs were approximately 9.2±2.3 nm in size for Cu°, (no surface oxide present), approximately 8.5±1.1 nm Ag° spheres, and approximately 8–80 nm for Au°.

Mixed alcohols can be used as a fuel additive in gasoline, diesel, jet fuel or as a neat fuel in and of itself. The mixed alcohols can contain C1-C5 alcohols, or in the alternative, C1-C8, or higher, alcohols in order to boost energy content. The C1-C5 mixed alcohols contain more ethanol than methanol with amounts of propanol, butanol and pentanol. C1-C8 mixed alcohols contain the same, with amounts of hexanol, heptanol and octanol. A gasoline-based fuel includes gasoline and the mixed alcohols. A diesel based fuel includes diesel and the mixed alcohols. A jet fuel includes kerosene and the mixed alcohols. The neat fuel of the mixed alcohols has an octane number of at least 109 and the Reid Vapor Pressure is no greater than 5 psi. The gross heat of combustion is at least 12,000 BTU's / lb.

The present application teaches a coating having a biologically compatible compound conjugated to, or blended with, a polymer, wherein the polymer includes at least one olefin-derived unit and at least one unit derived from a vinyl alcohol, an allyl alcohol, or derivatives thereof.

The invention provides a non-naturally occurring microbial organism having n-propanol and isopropanol pathways, 1,4-butanediol (14-BDO) and isopropanol pathways, 1,3-butanediol (13-BDO) and isopropanol pathways or methylacrylic acid (MAA) and isopropanolpathways. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in each of the respective n-propanol, 14-BDO, 13-BDO or MAA and isopropanol pathways. The invention additionally provides a method for co-producing n-propanol and isopropanol, 14-BDO and isopropanol, 13-BDO and isopropanol or MAA and isopropanol. The method can include culturing an n-propanol and an isopropanol co-producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding an n-propanol, an isopropanol, a 14-BDO, a 13-BDO and / or a MAA pathway enzyme in a sufficient amount to produce each of the respective products, under conditions and for a sufficient period of time to produce each of the respective products.

An exemplary printable composition of a liquid or gel suspension of diodes comprises a plurality of diodes, a first solvent and / or a viscosity modifier. In other exemplary embodiments a second solvent is also included, and the composition has a viscosity substantially between about 100 cps and about 25,000 cps at about 25° C. In an exemplary embodiment, a composition comprises: a plurality of diodes or other two-terminal integrated circuits; one or more solvents comprising about 15% to 99.9% of any of N-propanol, isopropanol, dipropylene glycol, diethylene glycol, propylene glycol, 1-methoxy-2-propanol, N-octanol, ethanol, tetrahydrofurfuryl alcohol, cyclohexanol, and mixtures thereof; a viscosity modifier comprising about 0.10% to 2.5% methoxy propyl methylcellulose resin or hydroxy propyl methylcellulose resin or mixtures thereof; and about 0.01% to 2.5% of a plurality of substantially optically transparent and chemically inert particles having a range of sizes between about 10 to about 50 microns.

The invention discloses a catalyst for synthesizing low carbon mixed alcohol with synthetic gas and a preparation method. The main components of the catalyst are copper oxide, zinc oxide, chromium oxide, alumina, and an appropriate amount of other assistants, which are expressed by the general formula Cu(Zn)a(Cr)b(Al)c(M)d(A)e(O)x; the catalyst is prepared by coprecipitation, and the assistant is added by impregnation. Under appropriate conditions, the catalyst can lead CO and hydrogen to react to produce a mixture of oxidation compounds which comprises methanol, ethanol, propanol, isobutanol, pentanol, and a small amount of C5.

The pharmaceutical preparation for transdermal administration contains solvent ingredients, such as water and ethanol and / or propanol, and drospirenone. The drospirenone is contained in the preparation in an amount that is not above its saturation solubility in an initial state prior to application to skin. However after application to the skin the amount of drospirenone exceeds its saturation solubility due to escape or discharge of the solvent ingredients from the preparation. Preferably the saturation solubility is exceeded by at least a factor of five during application to the skin. The pharmaceutical preparation can also contain an estrogen, such as ethinyl estradiol. It can be in the form of a semi-solid or liquid preparation that is contained in a reservoir-type transdermal patch. A transdermal patch for contraception containing the pharmaceutical preparation including drospirenone and ethinyl estradiol is also disclosed.

A method of preparing an olefin comprising: reacting a polyol in the presence of a carboxylic acid, such that an olefin is produced by the deoxygenation of the polyol. The reacting step can comprise (a) providing a composition comprising the polyol, (b) heating the composition, and (c) introducing the carboxylic acid to the composition wherein the introducing step occurs prior to, at the same time as, or subsequent to the heating step. In one embodiment, the polyol is glycerol, the carboxylic acid is formic acid, and the olefin is allyl alcohol, which is produced at a yield of about 80% or greater.

The invention relates to a sulfur removal agent suitable for the production of an oil-gas well. The sulfur removal agent comprises the following components in percentage by mass: 10 to 25 percent of hexahydro-1,3,5-tris(hydroxyethyl)-s-triazine, 5 to 20 percent of alcohol amine, 5 to 20 percent of small molecular alcohol and the balance of water. The alcohol amine is one or a mixture of more thantwo of monoethanolamine, ethyleneglycol amine, diisopropanolamine, methyldiethanolamine and triethanolamine; and the small molecular alcohol is one or a mixture of more than two of methanol, ethanol and propanol. The sulfur removal agent has a simple formula, can be soluble with water, and can effectively reduce the content of hydrogen sulfide in crude oil or natural gas; simultaneously, productsgenerated by the sulfur removal agent and the hydrogen sulfide are water-soluble, and cannot block a mineshaft and influence the normal production of the oil-gas well; and the sulfur removal agent can achieve effects at the temperature of 30 to 120 DEG C and can be quickly reacted with the hydrogen sulfide.

Compositions and lures are described which provide vapor blends of acetic acid and one or more compounds selected from the group consisting of isobutanol, racemic 2-methyl-1-butanol, S-(-)-2-methyl-1-butanol, 2-methyl-2-propanol, heptyl butyrate, and butyl butyrate which function as highly effective attractants for yellowjacket wasps and paper wasps. By attracting wasps to traps or baits, the chemical attractants provide a means for detecting, surveying, monitoring, and controlling the wasps.

The invention discloses a process for extracting litchi polyphenol from litchi through dissolvent abstraction, concentrating, separation and purification, and drying, wherein water or low carbon alcohols such as methanol, ethanol, propanol, isopropanol, butanol and amylic alcohol are used as the dissolvent.

The invention belongs to the technical field of chemical engineering, and discloses polyether modified organic silicone oil that adopts a comb structure shown in formula (1) and a preparation method and application as a defoamer, and overcomes the service restrictions of conventional organic silicone defoamers. The preparation method comprises the following steps: compounds such as short polyols polydimethyl siloxane or polymethyl phenyl siloxane in which end groups are hydrogen, allyl alcohol polyether, aliphatic esters or alkanes amides that contain end alkenyl are selected as raw materials to synthesize the polyether modified organic silicone oil. According to the invention, as a defoamer, the polyether modified organic silicone oil has good characteristics of self-emulsifying property, self-dispersing property, steady emulsifying property, good defoaming and foam inhibiting performance, high temperature resistance, and acid and alkali resistance.

A process for synthesizing a single isomer of a naphthacene compound comprises the steps of: (a) reacting a symmetrically substituted 1,1-diarylpropargyl alcohol compound with a reagent capable of forming a leaving group to form a reaction mixture containing a intermediate; and then (b) heating the intermediate in the presence of a solvent and in the absence of any oxidizing agent to form a single naphthacene compound.

A process for the preparation of an organosilicon condensate which comprises reacting together a silicon containing compound having at least one silanol group and a silicon containing compound having at least one —OR group or at least one silanol group (or a compound having both groups) in the presence of strontium oxide, barium oxide, strontium hydroxide or barium hydroxide and optionally a solvent such as water, methanol, ethanol, 1-propanol, 2-propanol, 1-butanol and 2-butanol, acetone or toluene.

A method for synthesizing propylene glycol methyl ether relates to a method for synthesizing propylene glycol methyl ether. The method of the invention settles the problems of high reaction temperature, high pressure, low activity of catalyst and low selectivity existing in the prior method for preparing propylene glycol methyl ether. The method comprises the following steps: 1. preparing a compound A; 2. preparing a compound B; and 3. after naturally cooling the mixed solution B to a room temperature, atmospherically distilling and obtaining the propylene glycol methyl ether. The method of the invention has the advantages of simple process, applicable whole reaction in the condition of normal pressure and low-temperature, 93.3%-94.2% of epoxy propane conversion rate, 98.1%-99.1% of product selectivity, and no environment pollution as the whole reaction process is executed under the condition of no dissolvent. The propylene glycol methyl ether (1-methoxy-2-propanol or 2-methoxy-1-propanol) synthesized according to the invention can be synthesized by regulating the mixed liquid of acetate methyl glyoxaline hydroxide or acetate methyl glyoxaline chloride and ferric trichloride.

A process for preparing hydrofluoroether features the reaction between one of trifluoroethene, tetrafluoroethene, hexafluoro propene, etc and one of trifluoroethanol, trifluoropropanol, metanol, etc in organic solvent (DMF or DMSO). Its advantages are high output rate and easy purifying and separating.

The present invention relates to a salt of carvedilol and / or corresponding solvates thereof, compositions containing such carvedilol and / or corresponding solvates thereof, and / or methods of using the aforementioned compound(s) in the treatment of certain disease states in mammals, in particular man. The present invention further relates to carvedilol phosphate salts, and / or solvates thereof, which include a novel crystalline form of carvedilol dihydrogen phosphate (i.e., which is the dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol) and / or carvedilol hydrogen phosphate, etc.) and / or other corresponding solvates thereof, compositions containing these carvedilol phosphate salts and / or solvates, and methods of using the aforementioned salts and / or solvates to treat hypertension, congestive heart failure and angina, etc.

The invention relates to a method for preparing a cationic grafting agent with multi-reactive groups, which comprises the following steps: adding N,N-dimethyl diaminopropane or N,N-dimethylaminoethanol and hydrochloride solution of N,N-dimethylamino propanol into cyanuric chloride water suspension at the temperature of 0-10 DEG C, leading the molar ratio of cyanuric chloride to the N,N-dimethyl diaminopropane or the N,N-dimethylaminoethanol and the N,N-dimethylamino propanol to be 1: 0.34, using base for adjusting and controlling the pH to be 3-4, increasing the temperature to 35-45 DEG C after full reaction, and further adding the N,N-dimethyl diaminopropane or the N,N-dimethylaminoethanol, leading the molar ratio of the N,N-dimethyl diaminopropane or the N,N-dimethylaminoethanol to the cyanuric chloride to be 0.4:1, using hydrochloric acid for adjusting the pH to be 1-2 after full reaction, increasing the temperature to 70-85 DEG C, adding epichlorohydrin, leading the molar ratio of the epichlorohydrin to the cyanuric chloride to be 0.7:1, and obtaining a monochlorotriazine ammonium chloride derivative. The grafting agent is used for graft modification of fabric, thereby improving the dyeing effect.

The invention relates to a synthesis method of epichlorohydrin, which is a reclaim utilization method of R-3-chloro-1, 2-propanediol during the separation and the preparation of S-epichlorohydrin by utilizing the dynamics of epichlorohydrin and a utilization method of utilizing glycerin which is the byproduct in the production of biodiesel. The R-3-chloro-1, 2-propanediol is reacted with chlorinating agent with the catalysis of the acid catalyst to generate the 1, 3-dichloro propanol, the obtained 1,3-dichloro propanol is reacted with alkali to generate the epichlorohydrin; the glycerin is reacted with the chlorinating agent with the catalysis of the acid catalyst to generate the 1,3-dichloro propanol, and the obtained 1,3-dichloro propanol is reacted with alkali to generate the epichlorohydrin. The synthesis method of the invention is simple, which can effectively convert the highly toxic waste R-3-chloro-1, 2-propanediol and the crude glycerin into the epichlorohydrin, the yield is high, the production cost is low, the environment pollution is reduced, so the synthesis method is an ideal method for industrialization reclaiming and utilization of R-3-chloro-1, 2-propanediol and the crude glycerin.

The invention relates to method and equipment system for separating and recovering organic oxygen-containing compounds in a Fischer-Tropsch synthesis water phase. The equipment system is integrated by adopting twelve towers including a mixed acid cutting tower, an acetaldehyde rectifying tower, a methanol / ethanol dividing tower, a methanol extraction rectifying tower, a methanol rectifying tower, an acetaldehyde removing tower, an ethanol tower, a propanol concentration extracting tower, a propanol intermittent azeotropic distillation tower, a carboxylic acid extraction tower, a carboxylic acid intermittent rectifying tower and an extraction agent recovering tower matched with the carboxylic acid extraction tower for use. By applying the method and equipment system disclosed by the invention, more than ten kinds of organic oxygen-containing compounds such as acetaldehyde, acetone, methanol, ethanol, normal propyl alcohol, normal butanol, acetic acid, metacetonic acid, butyric acid, butanone and the like can be separated from raw materials; and the products can respectively reach the industrial purity. The method and equipment provided by the invention are economic, effective and reasonable; and according to the method and equipment, efficiency of Fischer-Tropsch synthesis industrial enterprises can be greatly increased, production cost is reduced and goal of clean production can be achieved.

The present invention relates to extraction process of separating dihcloro propanol from hydrochloric acid aqua of dihcloro propanol in the dihcloro propanol yield over 90 % and the dihcloro propanol content in the extracted water phase lower than 0.05 %. The extraction equipment has simple structure, great treating capacity and low power consumption, and the extraction process has environment friendship, high dihcloro propanol recovering rate and is suitable for continuous industrial production. The present invention also provides the way of extracting other organic matter from hydrochloric acid aqua.

A process of producing a universal synthetic based gasoline fuel additive that cleans the fuel system including valves surface, lubricates the fuel pump, injectors and valves while allowing for a clean and more efficient burn. A major portion will consist of (a) Alfa-Olefins, (b) 2-propanol (c) Hydrolsomerized High VI HT Base Oils, (d) Dimethyl Ketones, (e) Low Flash Mineral Spirits, (f) Low Aromatic Solvent, (g) Isomer Reformate, (h) Solvent Activated Dye. In a preferred embodiment, this universal synthetic gasoline conditioner additive for improving lubrication comprises: alpha-olefins comprising from 5 to 30 percent thereof, by weight; low odor aromatic solvents comprising from 3 to 27 percent thereof, by weight; 2-Propanol comprising of 3 to 30 percent thereof, by weight; and at least one a base oil comprising from 0.50 to 15 percent thereof, by weight; wherein: the percentages by weight are specified in relative proportion to one another.